Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells
- 31 March 1996
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 31 (2-3) , 223-235
- https://doi.org/10.1016/0162-3109(95)00053-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Glucocorticoids suppressed production and gene expression of interleukin-5 by peripheral blood mononuclear cells in atopic patients and normal subjectsJournal of Allergy and Clinical Immunology, 1994
- Cytokines. 3. Cytokines in asthma.Thorax, 1993
- Increased Interleukin-4 Production by Atopic Mononuclear Leukocytes Correlates with Increased Cyclic Adenosine Monophosphate – Phosphodiesterase Activity and Is Reversible by Phosphodiesterase InhibitionJournal of Investigative Dermatology, 1993
- Modulation of TNFα and IL-1β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitorsInflammation Research, 1993
- Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.Thorax, 1991
- High pressure liquid chromatography of cyclic nucleotide phosphodiesterase from purified human T-lymphocytesBiochemical and Biophysical Research Communications, 1989
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988
- Effects of enprofylline and theophylline may show the role of adenosineLife Sciences, 1986
- Phosphodiesterase Inhibition by Ro 20-1724 Reduces Hyper-IgE Synthesis by Atopic Dermatitis Cells In VitroJournal of Investigative Dermatology, 1985
- Elevated leukocyte cyclic AMP—phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP—agonist hyporesponsivenessJournal of Allergy and Clinical Immunology, 1982